Fingerprint
Dive into the research topics of 'The dual inhibition of RNA Pol I transcription and PIM kinase as a new therapeutic approach to treat advanced prostate cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The dual inhibition of RNA Pol I transcription and PIM kinase as a new therapeutic approach to treat advanced prostate cancer
Richard J. Rebello, Eric Kusnadi, Donald P. Cameron, Helen B. Pearson, Analia Lesmana, Jennifer R. Devlin, Denis Drygin, Ashlee K. Clark, Laura Porter, John Pedersen, Shahneen Sandhu, Gail P. Risbridger, Richard B. Pearson*, Ross D. Hannan, Luc Furic
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
59
Citations
(Scopus)